| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―31 |
Solid-Phase Synthesis and Immunological Evaluation of Peptide Conjugates Containing Stereochemically Defined UPam-Based TLR2 Ligands and Epitopes from SARS-CoV-2 Virus |
Giulia Castello, Marjolein M.E. Isendoorn, Marcel Camps, Nico J. Meeuwenoord, Vincent F. H. Verhoeks, Thomas C. van den Ende, et al. (+3) Jeroen D. C. Codée, Ferry Ossendorp, Dmitri V. Filippov |
| 2 |
[GO] |
2025―Dec―25 |
A Dual-Targeted, Long-Circulating, and Intelligent-Responsive Antiviral Agent Suppresses SARS-CoV-2 by Blocking Viral Entry and Replication |
Jingyang Zhao, Peng Ye, Huatai Zhu, Yucheng Li, Jiandu Lei |
| 3 |
[GO] |
2025―Jul―16 |
Probing SARS-CoV-2 G-Quadruplexes in the Nsp3 Gene Segment by Fluorescence and 19F NMR Using a Functionalized Nucleoside Analog |
Sarupa Roy, Seergazhi G. Srivatsan |
| 4 |
[GO] |
2025―Feb―24 |
Gag HIV-1 Virus-like Particles and Extracellular Vesicles Functionalization with Spike Epitopes of SARS-CoV-2 Using a Copper-Free Click Chemistry Approach |
Marc García-Trujillo, Jesús Lavado-García, Arnau Boix-Besora, Francesc Gòdia, Laura Cervera |
| 5 |
[GO] |
2021―Nov―14 |
Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice |
Wei-Yun Wholey, Sekou-Tidiane Yoda, Wei Cheng |
| 6 |
[GO] |
2021―Sep―09 |
Correction to “Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys” |
Heng Li, Lei Guo, Huiwen Zheng, Jing Li, Xin Zhao, Jiaqi Li, et al. (+15) Yan Liang, Fengmei Yang, Yurong Zhao, Jinling Yang, Mengyi Xue, Yuanyuan Zuo, Jian Zhou, Yanli Chen, Zening Yang, Yanyan Li, Weihua Jin, Haijing Shi, Zhanlong He, Qihan Li, Longding Liu |
| 7 |
[GO] |
2021―Jun―28 |
SARS-CoV-2 Peptide Bioconjugates Designed for Antibody Diagnostics |
Ivan M. Ryzhov, Alexander B. Tuzikov, Alexey V. Nizovtsev, Ludmila K. Baidakova, Oxana E. Galanina, Nadezhda V. Shilova, et al. (+8) Marina M. Ziganshina, Nataliya V. Dolgushina, Guldana R. Bayramova, Gennady T. Sukhikh, Eleanor C. Williams, Radhika Nagappan, Stephen M. Henry, Nicolai V. Bovin |
| 8 |
[GO] |
2021―May―06 |
Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys |
Heng Li, Lei Guo, Huiwen Zheng, Jing Li, Xin Zhao, Jiaqi Li, et al. (+15) Yan Liang, Fengmei Yang, Yurong Zhao, Jinling Yang, Mengyi Xue, Yuanyuan Zuo, Jian Zhou, Yanli Chen, Zening Yang, Yanyan Li, Weihua Jin, Haijing Shi, Zhanlong He, Qihan Li, Longding Liu |
| 9 |
[GO] |
2020―Dec―24 |
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2 |
Ross C. Larue, Enming Xing, Adam D. Kenney, Yuexiu Zhang, Jasmine A. Tuazon, Jianrong Li, et al. (+3) Jacob S. Yount, Pui-Kai Li, Amit Sharma |
| 10 |
[GO] |
2020―Oct―18 |
Gold/Silver Hybrid Nanoparticles with Enduring Inhibition of Coronavirus Multiplication through Multisite Mechanisms |
Ting Du, Jinyu Zhang, Chunqiao Li, Tao Song, Ping Li, Jifeng Liu, et al. (+2) Xinjun Du, Shuo Wang |
| 11 |
[GO] |
2020―Jul―17 |
Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2 |
Deepak S. Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan, Murali M. Yallapu |
| 12 |
[GO] |
2020―Jul―08 |
The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis |
Edouard Alphandéry |
|
